European AI startup raises $24M for protein design software service
27 Nov 2023
PROTACs
A European startup is betting that drug companies big and small will look to outsource artificial intelligence expertise that can help design new protein-based medicines.
Cradle said Monday that it raised $24 million in Series A funding to refine its generative AI software for concocting new proteins or improving existing ones. And rather than building an internal pipeline of drug programs, Cradle is squarely a software-as-a-service company, CEO and co-founder Stef van Grieken told Endpoints News.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.